| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 25211 | 2017 |
| Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range T Battelino, T Danne, RM Bergenstal, SA Amiel, R Beck, T Biester, E Bosi, ... Diabetes care 42 (8), 1593-1603, 2019 | 3042 | 2019 |
| International consensus on use of continuous glucose monitoring T Danne, R Nimri, T Battelino, RM Bergenstal, KL Close, JH DeVries, ... Diabetes care 40 (12), 1631-1640, 2017 | 1896 | 2017 |
| State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018 C FosterNicole, W BeckRoy, M MillerKellee, A ClementsMark, ... Diabetes technology & therapeutics, 2019 | 1690 | 2019 |
| Threshold-based insulin-pump interruption for reduction of hypoglycemia RM Bergenstal, DC Klonoff, SK Garg, BW Bode, M Meredith, RH Slover, ... New England Journal of Medicine 369 (3), 224-232, 2013 | 788 | 2013 |
| Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial S Garg, H Zisser, S Schwartz, T Bailey, R Kaplan, S Ellis, L Jovanovic Diabetes care 29 (1), 44-50, 2006 | 773 | 2006 |
| Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes RM Bergenstal, S Garg, SA Weinzimer, BA Buckingham, BW Bode, ... Jama 316 (13), 1407-1408, 2016 | 695 | 2016 |
| Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. US Study Group of Insulin Glargine in Type 1 Diabetes. RE Ratner, IB Hirsch, JL Neifing, SK Garg, TE Mecca, CA Wilson Diabetes care 23 (5), 639-643, 2000 | 618 | 2000 |
| Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes SK Garg, SA Weinzimer, WV Tamborlane, BA Buckingham, BW Bode, ... Diabetes technology & therapeutics 19 (3), 155-163, 2017 | 615 | 2017 |
| Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP) RM Bergenstal, AJ Ahmann, T Bailey, RW Beck, J Bissen, B Buckingham, ... Diabetes technology & therapeutics 15 (3), 198-211, 2013 | 480 | 2013 |
| Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1 … S Heller, J Buse, M Fisher, S Garg, M Marre, L Merker, E Renard, ... The Lancet 379 (9825), 1489-1497, 2012 | 472 | 2012 |
| Clinical evaluation of the GlucoWatch® biographer: a continual, non-invasive glucose monitor for patients with diabetes MJ Tierney, JA Tamada, RO Potts, L Jovanovic, S Garg, ... Biosensors and Bioelectronics 16 (9-12), 621-629, 2001 | 461 | 2001 |
| Noninvasive glucose monitoring: comprehensive clinical results JA Tamada, S Garg, L Jovanovic, KR Pitzer, S Fermi, RO Potts, ... Jama 282 (19), 1839-1844, 1999 | 424 | 1999 |
| Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes SK Garg, S Schwartz, SV Edelman Diabetes Care 27 (3), 734-738, 2004 | 419 | 2004 |
| Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes HP Chase, SK Garg, G Marshall, CL Berg, S Harris, WE Jackson, ... Jama 265 (5), 614-617, 1991 | 417 | 1991 |
| Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. SK Garg, RO Potts, NR Ackerman, SJ Fermi, JA Tamada, HP Chase Diabetes care 22 (10), 1708-1714, 1999 | 408 | 1999 |
| Effects of sotagliflozin added to insulin in patients with type 1 diabetes SK Garg, RR Henry, P Banks, JB Buse, MJ Davies, GR Fulcher, P Pozzilli, ... New England Journal of Medicine 377 (24), 2337-2348, 2017 | 401 | 2017 |
| Continuous subcutaneous glucose monitoring in children with type 1 diabetes HP Chase, LM Kim, SL Owen, TA MacKenzie, GJ Klingensmith, ... Pediatrics 107 (2), 222-226, 2001 | 385 | 2001 |
| Diabetes and cancer: two diseases with obesity as a common risk factor SK Garg, H Maurer, K Reed, R Selagamsetty Diabetes, Obesity and Metabolism 16 (2), 97-110, 2014 | 357 | 2014 |
| Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised … P Dandona, C Mathieu, M Phillip, L Hansen, SC Griffen, D Tschöpe, ... The lancet Diabetes & endocrinology 5 (11), 864-876, 2017 | 305 | 2017 |
